Cigarette Smoke Modulates Vascular Smooth Muscle Phenotype: Implications for Carotid and Cerebrovascular Disease

Background The role of smooth muscle cell (SMC) phenotypic modulation in the cerebral circulation and pathogenesis of stroke has not been determined. Cigarette smoke is a major risk factor for atherosclerosis, but potential mechanisms are unclear, and its role in SMC phenotypic modulation has not been established. Methods and Results In cultured cerebral vascular SMCs, exposure to cigarette smoke extract (CSE) resulted in decreased promoter activity and mRNA expression of key SMC contractile genes (SM-α-actin, SM-22α, SM-MHC) and the transcription factor myocardin in a dose-dependent manner. CSE also induced pro-inflammatory/matrix remodeling genes (MCP-1, MMPs, TNF-α, IL-1β, NF-κB). CSE increased expression of KLF4, a known regulator of SMC differentiation, and siKLF4 inhibited CSE induced suppression of SMC contractile genes and myocardin and activation of inflammatory genes. These mechanisms were confirmed in vivo following exposure of rat carotid arteries to CSE. Chromatin immune-precipitation assays in vivo and in vitro demonstrated that CSE promotes epigenetic changes with binding of KLF4 to the promoter regions of myocardin and SMC marker genes and alterations in promoter acetylation and methylation. Conclusion CSE exposure results in phenotypic modulation of cerebral SMC through myocardin and KLF4 dependent mechanisms. These results provides a mechanism by which cigarette smoke induces a pro-inflammatory/matrix remodeling phenotype in SMC and an important pathway for cigarette smoke to contribute to atherosclerosis and stroke.

[1]  Esther Lutgens,et al.  Inflammation and immune system interactions in atherosclerosis , 2013, Cellular and Molecular Life Sciences.

[2]  Prabhat Jha,et al.  21st-century hazards of smoking and benefits of cessation in the United States. , 2013, The New England journal of medicine.

[3]  W. Koch,et al.  Cigarette Smoke and Inflammation: Role in Cerebral Aneurysm Formation and Rupture , 2012, Mediators of inflammation.

[4]  W. Koch,et al.  Biology of Intracranial Aneurysms: Role of Inflammation , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[6]  G. Owens,et al.  Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms. , 2012, Physiological genomics.

[7]  G. Owens,et al.  Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. , 2012, Annual review of physiology.

[8]  W. Koch,et al.  Abstract 110: Tumor Necrosis Factor-alpha Induces Phenotypic Modulation in Cerebral Vascular Smooth Muscle Cells via KLF4: Implications for Cerebral Aneurysm Pathology , 2012, Stroke.

[9]  G. Owens,et al.  Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. , 2012, The Journal of clinical investigation.

[10]  V. Gahtan,et al.  The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin. , 2011, American journal of surgery.

[11]  P. Mazzone,et al.  In Vitro Assessment of Tobacco Smoke Toxicity at the BBB: Do Antioxidant Supplements Have a Protective Role? , 2011, BMC Neuroscience.

[12]  A. Mirza,et al.  Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. , 2011, Atherosclerosis.

[13]  ZiadMallat,et al.  Recent Advances on the Role of Cytokines in Atherosclerosis , 2011 .

[14]  A. Tedgui,et al.  Recent Advances on the Role of Cytokines in Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Seemant Chaturvedi,et al.  Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[16]  J. van Benthem,et al.  Hazardous Compounds in Tobacco Smoke , 2011, International journal of environmental research and public health.

[17]  P. Mazzone,et al.  Pathophysiological Impact of Cigarette Smoke Exposure on the Cerebrovascular System with a Focus on the Blood-brain Barrier: Expanding the Awareness of Smoking Toxicity in an Underappreciated Area , 2010, International journal of environmental research and public health.

[18]  L. Edvinsson,et al.  Cigarette Smoke Extract Promotes Human Vascular Smooth Muscle Cell Proliferation and Survival through ERK1/2- and NF-κB–Dependent Pathways , 2010, TheScientificWorldJournal.

[19]  Y. Shoenfeld,et al.  Effects of tobacco smoke on immunity, inflammation and autoimmunity. , 2010, Journal of autoimmunity.

[20]  T. Olsen,et al.  Hemorrhagic and Ischemic Strokes Compared: Stroke Severity, Mortality, and Risk Factors , 2009, Stroke.

[21]  Mei Han,et al.  Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. , 2008, Journal of biochemistry.

[22]  R. de Cabo,et al.  Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. , 2008, American journal of physiology. Heart and circulatory physiology.

[23]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[24]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[25]  N. Leitinger,et al.  Oxidized Phospholipids Induce Phenotypic Switching of Vascular Smooth Muscle Cells In Vivo and In Vitro , 2007, Circulation research.

[26]  O. McDonald,et al.  Programming smooth muscle plasticity with chromatin dynamics. , 2007, Circulation research.

[27]  P. Ferdinandy,et al.  Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. , 2007, American journal of physiology. Heart and circulatory physiology.

[28]  G. Owens,et al.  Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. , 2007, American journal of physiology. Cell physiology.

[29]  E. Creemers,et al.  Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development , 2006, Development.

[30]  N. Leitinger,et al.  Oxidized Phospholipids Alter Vascular Connexin Expression, Phosphorylation, and Heterocellular Communication , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Martin Bendszus,et al.  Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization , 2006, Stroke.

[32]  Danny Reinberg,et al.  Histone Lysine Demethylases and Their Impact on Epigenetics , 2006, Cell.

[33]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[34]  Irene Katzan,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Stroke.

[35]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[36]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[37]  Richard T. Lee,et al.  Smoking, Metalloproteinases, and Vascular Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[38]  O. McDonald,et al.  Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. , 2005, The Journal of clinical investigation.

[39]  Sucharita SenBanerjee,et al.  Kruppel-like Factor 4 Is a Mediator of Proinflammatory Signaling in Macrophages* , 2005, Journal of Biological Chemistry.

[40]  Sanjay Sinha,et al.  Kruppel-like Factor 4 Abrogates Myocardin-induced Activation of Smooth Muscle Gene Expression* , 2005, Journal of Biological Chemistry.

[41]  A. Schober,et al.  Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[42]  G. Owens,et al.  Molecular Determinants of Vascular Smooth Muscle Cell Diversity , 2005, Circulation research.

[43]  B. Sumpio,et al.  Nicotine induces mitogen-activated protein kinase dependent vascular smooth muscle cell migration. , 2005, Atherosclerosis.

[44]  O. McDonald,et al.  A G/C Element Mediates Repression of the SM22&agr; Promoter Within Phenotypically Modulated Smooth Muscle Cells in Experimental Atherosclerosis , 2004, Circulation research.

[45]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[46]  J. Ambrose,et al.  The pathophysiology of cigarette smoking and cardiovascular disease: an update. , 2004, Journal of the American College of Cardiology.

[47]  Jian-Mei Li,et al.  Nicotine Enhances Angiotensin II-Induced Mitogenic Response in Vascular Smooth Muscle Cells and Fibroblasts , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[48]  G. Rosenberg.  Matrix metalloproteinases in neuroinflammation , 2002, Glia.

[49]  M. Sopori,et al.  Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.

[50]  G. Owens,et al.  Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. , 2000, The Journal of clinical investigation.

[51]  J. McNeil,et al.  Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. , 1999, American journal of public health.

[52]  P. Whelton,et al.  Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.

[53]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[54]  D. Strachan,et al.  Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. , 1997, Heart.

[55]  P. Gunning,et al.  Actin and tropomyosin isoforms in morphogenesis , 1997, Anatomy and Embryology.

[56]  G. Owens,et al.  Expression of the Smooth Muscle Myosin Heavy Chain Gene Is Regulated by a Negative-acting GC-rich Element Located between Two Positive-acting Serum Response Factor-binding Elements* , 1997, The Journal of Biological Chemistry.

[57]  J. Deanfield,et al.  Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.

[58]  I. Pichová,et al.  The cleavage of host cell proteins by HIV-1 protease. , 1996, Folia biologica.

[59]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[60]  T. Yue,et al.  Interleukin-1β induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells , 1995 .

[61]  S. Kono,et al.  Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis. , 1995, Cardiology.

[62]  T. Yue,et al.  Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. , 1995, Atherosclerosis.

[63]  M. Szklo,et al.  The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. , 1995, Preventive medicine.

[64]  J. Schwartz,et al.  Cigarette smoking and peripheral blood leukocyte differentials. , 1994, Annals of epidemiology.

[65]  D. Celermajer,et al.  Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.